Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1AFAMELANOTIDE1件: Afamelanotide1件: D10511 1件: MC1R 💬2件: Melanogenesis, Neuroactive ligand-receptor interaction 💬2件: 159, 254
2Afamelanotide (16 mg implant)1件: Afamelanotide1件: D10511 1件: MC1R 💬2件: Melanogenesis, Neuroactive ligand-receptor interaction 💬1件: 159
3Ipilimumab1件: Ipilimumab1件: D04603 1件: CTLA4 💬4件: Autoimmune thyroid disease, Cell adhesion molecules, Rheumatoid arthritis, T cell receptor signaling pathway 💬1件: 159
4Isotretinoin1件: Isotretinoin1件: D00348 2件: RARA,
RARB 💬		8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬4件: 36, 39, 159, 160
5Liposomal T4N5 lotion----1件: 159
6Nivolumab1件: Nivolumab1件: D10316 1件: PDCD1 💬3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159
7SCENESSE1件: Afamelanotide1件: D10511 1件: MC1R 💬2件: Melanogenesis, Neuroactive ligand-receptor interaction 💬3件: 159, 161, 254
8TRABECTEDINA1件: Trabectedin1件: D06199 --1件: 159
9Trabectedine----1件: 159
10Yondelis1件: Trabectedin1件: D06199 --1件: 159
11YONDELIS 0,25 mg polvo para concentrado para solución para perfusión1件: Trabectedin1件: D06199 --1件: 159
12Yondelis 0.25 mg powder for concentrate for solution for infusion.1件: Trabectedin1件: D06199 --1件: 159
13YONDELIS 1 mg polvo para concentrado para solución para perfusión1件: Trabectedin1件: D06199 --1件: 159
14Yondelis 1 mg powder for concentrate for solution for infusion.1件: Trabectedin1件: D06199 --1件: 159